NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/janelle-lawrence
Sign In To follow
The verdict signals that the public is willing to hold pharmaceutical executives accountable for the U.S. crisis.
The trial of Insys Therapeutics Inc. CEO John Kapoor could serve as a test-drive for how jurors weigh claims of industry wrongdoing.